These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 1661602)
1. Current applications of monoclonal antibodies for the therapy of hematopoietic cancers. Scheinberg DA Curr Opin Immunol; 1991 Oct; 3(5):679-84. PubMed ID: 1661602 [TBL] [Abstract][Full Text] [Related]
2. Monoclonal antibody therapy of lymphomas and leukemia. Kaminski MS; Foon KA Cancer Treat Res; 1988; 38():253-63. PubMed ID: 2908598 [No Abstract] [Full Text] [Related]
3. Biologicals for cancer treatment: monoclonal antibodies. Levy R Hosp Pract (Off Ed); 1985 Nov; 20(11):67-74, 77, 80-4 passim. PubMed ID: 3932392 [No Abstract] [Full Text] [Related]
4. Antibodies in the treatment of lymphoma. Harvey ML; Illidge T; Johnson P Clin Oncol (R Coll Radiol); 2001; 13(4):251-61. PubMed ID: 11554621 [No Abstract] [Full Text] [Related]
5. Treatment of lymphoid tumors with anti-idiotype antibodies. Stevenson GT; Stevenson FK Springer Semin Immunopathol; 1983; 6(1):99-115. PubMed ID: 6351310 [No Abstract] [Full Text] [Related]
6. Monoclonal antibodies in the study and therapy of hematopoietic cancers. Matthews DC; Smith FO; Bernstein ID Curr Opin Immunol; 1992 Oct; 4(5):641-6. PubMed ID: 1418732 [TBL] [Abstract][Full Text] [Related]
8. Idiotypic manipulation of the antibody response to a retrovirus-induced tumor. Powell TJ; Lamon EW Prog Clin Biol Res; 1989; 288():289-93. PubMed ID: 2785691 [No Abstract] [Full Text] [Related]
9. Anti-idiotype antibodies reveal the existence of somatic mutation in human B cell lymphoma. Levy R; Levy S; Brown SL; Kon S; Carroll W Monogr Allergy; 1987; 22():194-203. PubMed ID: 3325832 [No Abstract] [Full Text] [Related]
10. [Serotherapy of leukemia and lymphoma using monoclonal antibodies]. Rupniewska ZM Pol Tyg Lek; 1985 Aug; 40(33):942-7. PubMed ID: 2997760 [No Abstract] [Full Text] [Related]
11. Monoclonal anti-Id antibodies react with varying proportions of human B lineage cells. Kiyotaki M; Cooper MD; Bertoli LF; Kearney JF; Kubagawa H J Immunol; 1987 Jun; 138(12):4150-8. PubMed ID: 3495581 [TBL] [Abstract][Full Text] [Related]
12. Vaccines in lymphoma. Levy R Clin Adv Hematol Oncol; 2004 Jul; 2(7):424, 427. PubMed ID: 16163215 [No Abstract] [Full Text] [Related]
13. Clinical applications of monoclonal antibodies for patients with leukemia and lymphoma. Foon KA; Schroff RW; Bunn PA Prog Clin Biol Res; 1986; 211():265-84. PubMed ID: 3515361 [No Abstract] [Full Text] [Related]
14. Derivatives of anti-idiotype antibodies in the treatment of B-cell lymphoma. Glennie MJ; Stevenson GT Adv Exp Med Biol; 1985; 186():843-53. PubMed ID: 3876727 [No Abstract] [Full Text] [Related]
15. Role of antibody therapy in lymphoid malignancies. Dearden CE Br Med Bull; 2007; 83():275-90. PubMed ID: 17942451 [TBL] [Abstract][Full Text] [Related]
16. Screening for anti-idiotypic monoclonal antibodies on paraformaldehyde-fixed lymphoma cells. Samoszuk M; Sholly S; Epstein AL Hybridoma; 1987 Dec; 6(6):605-10. PubMed ID: 3325402 [TBL] [Abstract][Full Text] [Related]
17. Monoclonal antibodies raised against the idiotype of the murine B cell lymphoma, BCL1 act primarily with heavy chain determinants. George AJ; McBride HM; Glennie MJ; Smith LJ; Stevenson FK Hybridoma; 1991 Apr; 10(2):219-27. PubMed ID: 1908435 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of alternative methodologies for the generation of murine monoclonal anti-idiotypic antibodies to human B cell leukemias and lymphomas. Giardina SL; Foon KA; Beatty SM; Morgan AC J Immunol Methods; 1986 May; 89(1):1-7. PubMed ID: 3517169 [TBL] [Abstract][Full Text] [Related]
19. Tumor-specific idiotype vaccines. I. Generation and characterization of internal image tumor antigen. Raychaudhuri S; Saeki Y; Fuji H; Kohler H J Immunol; 1986 Sep; 137(5):1743-9. PubMed ID: 3018080 [TBL] [Abstract][Full Text] [Related]